Physician profile
Ryan Jones
NPI 1861019010
$925.17
in general payments reported to CMS, 2019-2025
17 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.23 · 2022: $36.49 · 2023: $137 · 2024: $517 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787 · Education: $46.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.29 |
| Education | $46.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $161.93 | 2023-2025 | Mounjaro, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $159.48 | 2023-2024 | |
| Amgen INC. | $91.69 | 2024 | Tepezza, Evenity, Prolia |
| Novo Nordisk INC | $85.60 | 2024-2025 | Wegovy |
| Pfizer INC. | $63.75 | 2023-2024 | |
| Vyne Pharmaceuticals INC. | $55.23 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.14 | 2022-2024 | |
| Leo Pharma INC. | $51.07 | 2025 | Adbry |
| Lucid Diagnostics INC. | $35.38 | 2025 | |
| Exact Sciences Corporation | $34.41 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $28.74 | 2024 | Airsupra, Farxiga |
| Astellas Pharma US INC | $22.74 | 2024 | Veozah |
| Abbvie INC. | $21.35 | 2023 | |
| Inari Medical, INC. | $18.10 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Almirall LLC | $16.25 | 2023 | Seysara |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $13.01 | 2023 | Nocdurna, Tlando, Xyosted |
| Sun Pharmaceutical Industries INC. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.